Mumbai, India (CU)_ Dr. Reddy’s Laboratories and Natco Pharma made a statement announcing that generic capsules for the treatment of multiple myeloma and myelodysplastic syndrome patients were launched in the Canadian market. According to the companies’ statements in a separate regulatory filings, the pharma companies’ Canadian businesses have released Reddy-Lenalidomide and Nat-Lenalidomide capsules, which are generic copies of Revlimid that have been approved by Health Canada.
According to Vinod Ramachandran, Dr Reddy’s Laboratories Canada Vice President and General Manager, “Our launch of…
